Chewy Expands Vet Clinics And Buybacks In Bid For Pet Care Scale

• Chewy (NYSE:CHWY) is acquiring Modern Animal, a veterinary platform with nearly 30 clinics, to expand its pet health services footprint.
• The deal will more than double Chewy's clinic presence and introduce additional technology driven service models and recurring revenue streams.
• Chewy is also increasing its share repurchase authorization by $500 million, signaling management's confidence in the company's direction.

For investors tracking NYSE:CHWY, this move comes as the stock trades around $26.0, with a value score of 2 and a mixed return profile that includes a 22.4% decline year to date and a 20.2% decline over the past year. Over a longer period, Chewy's 3 year and 5 year returns of 25.4% and 70.0% declines, respectively, illustrate how much sentiment has reset around the company.

The Modern Animal acquisition and expanded buyback program represent a notable change in how Chewy is positioning itself within pet healthcare and capital allocation. As integration plans, clinic performance and share repurchases unfold, investors may want to track how these decisions affect earnings mix, cash use and Chewy's development toward a more fully integrated pet care platform.

Stay updated on the most important news stories for Chewy by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Chewy.

We've flagged 1 risk for Chewy. See which could impact your investment.

Chewy’s move to buy Modern Animal looks like a clear attempt to rebalance its business mix away from pure e-commerce and deeper into pet health services. Folding 29 membership-based clinics and 24/7 virtual care into Chewy Vet Care moves the company closer to its goal of being a full pet healthcare ecosystem, not just a pet supplies retailer competing with Amazon, Petco and Walmart. Management expects the acquired clinics to contribute over US$125 million in annual revenue and to be accretive to earnings per share within the first year after closing, which matters for a company that has faced margin pressure even as free cash flow reached a record US$562.4 million in 2025.

How This Fits Into The Chewy Narrative

• The acquisition supports the existing thesis that vet clinics and services can broaden Chewy’s presence in a roughly US$25b vet services market and deepen engagement beyond Autoship orders.
• Running nearly 50 clinics introduces more operational complexity and execution risk, which could challenge expectations for a smooth path toward higher margins.
• The specific contribution of Modern Animal’s high-retention membership model and 24/7 virtual care may not be fully captured in earlier narrative work that focused more on Chewy-branded clinics and the ad platform.

Knowing what a company is worth starts with understanding its story. Check out one of the top narratives in the Simply Wall St Community for Chewy to help decide what it's worth to you.

The Risks and Rewards Investors Should Consider

• ⚠️ Integration risk from combining 29 Modern Animal clinics with Chewy’s existing 18 locations, including culture, systems and physician retention.
• ⚠️ Higher capital needs and ongoing operating costs for physical clinics could pressure margins if utilization or membership growth falls short of expectations.
• 🎁 Additional services revenue from Modern Animal, with expectations for more than US$125 million in annual revenue and targeted US$250 million in vet revenue by 2027.
• 🎁 The enlarged clinic network, alongside Autoship contributing over 83% of sales, could deepen recurring revenue and support more stable free cash flow.

What To Watch Going Forward

From here, focus on how quickly Chewy integrates Modern Animal and whether membership retention and clinic-level economics hold up inside a larger organization. The company’s past margin pressure makes it important to track whether management can run nearly 50 clinics while still pushing toward better profitability, especially as it invests in AI-powered tools and other growth initiatives. The expanded US$500 million share repurchase authorization also deserves attention, as it affects how much cash is available for clinic build-outs and technology projects.

To stay updated on how the latest news impacts the investment narrative for Chewy, visit the community page for Chewy to never miss an update on the top community narratives.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com